Regeneron Finalizes Praluent® (alirocumab) Restructuring and Updates Accounting Presentation
Go back to Regeneron Finalizes Praluent® (alirocumab) Restructuring and Updates Accounting Presentation| Regeneron (NASDAQ: REGN) | Delayed: 799.08 +4.89 (0.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $794.19 | 52 Week High | $592.36 | |||
| Open | $782.44 | 52 Week Low | $325.35 | |||
| Day High | $802.78 | P/E | 209.73 | |||
| Day Low | $779.08 | EPS | $3.81 | |||
| Volume | 894,931 | |||||

